Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease
Laura Carrasco Hernández, Rosa Girón, Mari Nieves Balaguer Cartagena, Adrián Peláez, Amparó Solé, Antonio Álvarez Fernández, Almudena Felipe Montiel, Casilda Olveira, Gabriel Olveira, Ainhoa Gómez Bonilla, Beatriz Gomez Crespo, Marta García‐Clemente, Marta Solís García, Joana Quaresma Vázquez, E.B Viveiros de Castro, Jesús Rodríguez González, Andrea Expósito Marrero, Laila Diab-Cáceres, Cristina Ramos‐Hernández, Ester Zamarrón, Concha Prados Sanchez, Marina Blanco‐Aparicio, A. López Neyra, Verónica Sanz Santiago, C Paredes, Isabel Delgado Pecellı́n, Oscar A. Cruz, Esther Quintana‐Gallego
Topics & Concepts
IvacaftorCystic fibrosisMedicineInternal medicineGastroenterologyAdverse effectQuality of life (healthcare)Lung functionObservational studyLung transplantationLungCystic fibrosis transmembrane conductance regulatorNursingCystic Fibrosis Research AdvancesBiological Research and Disease StudiesDelphi Technique in Research